Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Background: The prevalence of type 2 diabetes (T2D) in youth is increasing. Treatment options beyond metformin and insulin are needed. The safety, tolerability, pharmacokinetics, and pharmacodynamics of liraglutide once daily in youth (10–17 years old) with T2D were investigated in a randomized, dou...

Full description

Saved in:
Bibliographic Details
Main Authors: Klein, David J., Battelino, Tadej, Chatterjee, D.J., Jacobsen, Lisbeth V., Hale, Paula M., Arslanian, Silva
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2014
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4183917/
https://ncbi.nlm.nih.gov/pubmed/25036533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2013.0366
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items